Search Results
Dec 02, 2025, 10:59 ET Botanica Celebrates the Success of Its Reclaimed Water Project
water testing conducted in partnership with the City of Wichita's new Water Treatment Plant. The reclaimed water was thoroughly evaluated to ensure it met all quality and safety requirements for irrigation use. Once approved, the new system began supplying reclaimed water directly to Botanica's 20+ acres
More news about: Botanica, The Wichita Gardens
Dec 02, 2025, 09:00 ET IMS Receives Frost & Sullivan's 2025 North America Technology Innovation Leadership Recognition for Connected and Telematics Insurance
to our customers. We believe that the technological and market conditions for the genuine mainstreaming of 'connected' auto insurance have now been met, so to be at the forefront of enabling fairer-priced cover and creating safer roads is an exciting place to be for our business."Frost & Sullivan
More news about: Frost & Sullivan
Dec 02, 2025, 09:00 ET IMS Receives Frost & Sullivan's 2025 North America Technology Innovation Leadership Recognition for Connected and Telematics Insurance
to our customers. We believe that the technological and market conditions for the genuine mainstreaming of 'connected' auto insurance have now been met, so to be at the forefront of enabling fairer-priced cover and creating safer roads is an exciting place to be for our business."Frost & Sullivan
More news about: Frost & Sullivan
Dec 02, 2025, 09:00 ET Allworth Financial Strengthens Up-Market Capabilities in Boston Through FSA Wealth Management Acquisition
For FSA's leadership, the decision to join Allworth was rooted in a shared client-first focus and strong cultural alignment."From the moment I met John, it was clear that Allworth is led by someone who truly understands the RIA industry and the growing complexity advisors face as client expectations
More news about: Allworth Financial
Dec 02, 2025, 09:00 ET Scotch Brand partners with Ego Nwodim to inspire joyful holiday gifting
gift bags behind and transform ordinary gifting moments into extraordinary experiences with Scotch Gift-Wrap Tape —so every wrapping and unwrapping is met with smiles, laughter, and true holiday cheer.See how Ego Nwodim takes on Resting Gift Face this holiday with Scotch Brand – watch the campaign
More news about: 3M Company
Dec 02, 2025, 08:57 ET Tiger Group Offers Assets from Turf Company's Georgia Plant
twister (less than 5 hours of use)Allma/Saurer Technocorder twisterATI PD96 3D precision laser box grader(2) Jacobsen Turfco Met-R-Matic XL topdressers(4) model 920HDE GreensGroomer turf brushes(2) Hot Melt Technologies Benchmark 315 portable hot melt gluersRAW
More news about: Tiger Group
Dec 02, 2025, 08:55 ET Hyundai Motor America Reports November 2025 Sales
President and CEO José Muñoz Shares Strategic Vision for 2026 at 2025 Leaders Talk: Hyundai Motor Company President and CEO José Muñoz met with employees around the world to share the company's
More news about: Hyundai Motor America
Dec 02, 2025, 08:50 ET Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances
not be able to secure additional capital on attractive terms, if at all; the risk that the therapeutic and commercial potential of NanoAbs will not be met or that Scinai will not be successful in bringing the NanoAbs towards commercialization; the risk of a delay in the preclinical and clinical trials data
More news about: Scinai Immunotherapeutics Ltd.
Dec 02, 2025, 08:15 ET AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers
CLL.3 The study was designed to test non-inferiority of VO vs I and VI vs I.3After a median follow-up of 34.2 months, the study met non-inferiority endpoints for the VO arm compared to I arm (HR 0.87, type-I-error adjusted CI [98.3%] 0.54-1.41) and for VI arm compared to I arm (HR
More news about: AbbVie Inc.
Dec 02, 2025, 08:00 ET Curaleaf Enters into an Equity Purchase Agreement for the Virginia Assets of The Cannabist Company
fully-operational cultivation facility and five retail dispensaries and the right to open one additional dispensary. Assuming all closing conditions are met, Curaleaf anticipates the transaction closing in the first quarter of 2026.
More news about: Curaleaf Holdings, Inc.
Dec 02, 2025, 07:07 ET PowerBank Announces Safe Harbor of 15 Distributed Solar and Energy Storage Projects in New York State
Beautiful Bill Act of 2025. Physical work on the procured equipment is expected to safe harbor the Projects by December 31, 2025. The Projects will have met the IRS Physical Work Test prior to the July 4, 2026 deadline under the United States One Big Beautiful Bill Act.
More news about: PowerBank Corporation
Dec 02, 2025, 06:20 ET Aluminum Recycling Market to Reach US$91.3 Billion by 2032 as Global Demand for Low-Carbon Metals & Circular Manufacturing Surges
recyclability. Rapid population and economic growth over the coming decade mean that global demand for aluminium will double through to 2050, and this will be met by 50% to 60% recycled metal. Producing aluminium from scrap requires only 5% of the energy needed for bauxite-based production, delivering over 16 tonnes
More news about: DataM Intelligence 4 Market Research LLP
Dec 02, 2025, 03:30 ET Xeltis secures nearly €50m from the European Investment Bank (EIB) and existing shareholders to advance aXess, its vascular access conduit to the market
of aXess in adult patients with end-stage renal disease requiring vascular access to start or maintain hemodialysis therapy. The study successfully met its primary endpoints, demonstrating standout sustained patency rates and significant improvements across all key measures, such as reduced infection
More news about: Xeltis
Dec 02, 2025, 03:23 ET À l'occasion du 19e Congrès européen sur les céphalées, AbbVie va présenter les données de la phase 3 d'ECLIPSE démontrant la supériorité de l'atogépant (AQUIPTA®) par rapport au placebo dans le soulagement complet de la douleur pour le traitement aigu de la migraine
autres expressions similaires, ainsi que l'utilisation de verbes au futur ou au conditionnel, identifient généralement les énoncés prospectifs. AbbVie met en garde contre le fait que ces énoncés prospectifs sont soumis à des risques et à des incertitudes qui peuvent engendrer des écarts considérables entre
More news about: AbbVie
Dec 02, 2025, 03:00 ET La précision de Ziwig Endotest® est confirmée par ENDOmiRNA, la plus grande étude mondiale menée sur un biomarqueur salivaire dans le diagnostic de l'endométriose
précision diagnostique de Ziwig Endotest®, associée à une sensibilité et à une spécificité très élevées, respectivement de 97,3% et 94,1%.Elle met en évidence la reproductibilité des performances de Ziwig Endotest®, qui n'est influencée ni par les facteurs géographiques ou temporels (centre d'inclusion,
More news about: Ziwig
Dec 02, 2025, 03:00 ET EcoOnline aviation forum highlights critical need for real-time, connected safety
As aviation leaders met to discuss the risks of disconnected systems, many are partnering with EcoOnline to strengthen protection from the ground to the air.LONDON, Dec. 2, 2025 /PRNewswire/ -
More news about: EcoOnline
Dec 02, 2025, 02:00 ET La plateforme MediaGo honorée pour la deuxième année consécutive dans la catégorie AdTech des Global Tech Awards
Les Global Tech Awards comptent parmi les reconnaissances de référence les plus influentes dans le secteur des technologies. La catégorie AdTech met en lumière l'application de l'innovation technologique dans le domaine de la publicité en récompensant les plateformes et les solutions qui améliorent
More news about: MediaGo
Dec 02, 2025, 02:00 ET Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health
OSVYRTI and JUBEREQThe approval of OSVYRTI and JUBEREQ was based on results from two trials: a Phase I trial and a Phase III trial that met their primary endpoints. The Phase I trial was a randomized, double-blind, three-arm pharmacokinetic (PK) study comparing JUBEREQ to Xgeva in healthy
More news about: Accord Healthcare
Dec 02, 2025, 02:00 ET Accord Healthcare Announces Launch of Denosumab∇ - Second Biosimilar in Bone Health
OSVYRTI and JUBEREQThe approval of OSVYRTI and JUBEREQ was based on results from two trials: a Phase I trial and a Phase III trial that met their primary endpoints. The Phase I trial was a randomized, double-blind, three-arm pharmacokinetic (PK) study comparing JUBEREQ to Xgeva in healthy
More news about: Accord Healthcare
Dec 01, 2025, 21:21 ET CCTV+: China-Africa Scientists Join Forces to Unlock the Potential of Africa's Oil Crops Sector
policymakers, researchers and private-sector representatives from Algeria, Egypt, Ethiopia, Mali, Madagascar, Nigeria, Tanzania and other countries met with their Chinese counterparts in Wuhan at the "Belt and Road Forum on Oil Crops Science, Technology Innovation and Industrial Cooperation". The forum,
More news about: CCTV+
Dec 01, 2025, 16:42 ET FaceTec 3D Liveness Passes Level 3 PAD & Level 5 IAD from both Ingenium and BixeLab
APCER on Level 3 Masks100% detection of injection attacks>40 attack types (e.g., emulators, hooking, rooted devices)BPCER met; tested on Android SDK v9.7.92Ingenium is an independent, ISO/IEC 17025:2017 and FIDO-accredited test laboratory, with accreditation granted
More news about: FaceTec, Inc.
Dec 01, 2025, 13:48 ET FirstEnergy Foundation Helps Power the Future with $10,000 Grant to York College
to help underprivileged high school students in York City explore careers in science, technology, engineering and mathematics fields. FirstEnergy and Met-Ed employees have also volunteered countless hours of their time over the years to mentor York College students and share real-world insights from the
More news about: FirstEnergy Corp.
Dec 01, 2025, 12:00 ET Citius Oncology Announces U.S. Commercial Launch of LYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL)
formulation for the relief of hemorrhoids. A pivotal Phase 3 trial for Mino-Lok and a Phase 2b trial for Halo-Lido were completed in 2023. Mino-Lok met primary and secondary endpoints of its Phase 3 trial. Citius Pharma is actively engaged with the FDA to outline next steps for both programs. Citius
More news about: Citius Oncology, Inc.
Dec 01, 2025, 11:03 ET Hoe VinFast Een Duurzame Toekomst Vanaf de Basis Opbouwt
6 en VF 8, zijn ontworpen om duurzaamheid, praktisch nut en waarde te combineren.De VF 6, ontwikkeld in samenwerking met Torino Design, heeft een Europese uitstraling met compacte proporties en krachtige lijnen. Vanaf €33.990 (Eco) en €37.990 (Plus) biedt hij tot 410 km rijbereik (WLTP) en ondersteunt
More news about: VinFast
Dec 01, 2025, 10:50 ET Comment VinFast Construit un Avenir Durable Depuis les Fondations
Soutenu par sa société mère Vingroup, l'une des entreprises privées les plus importantes et dynamiques d'Asie du Sud-Est, VinFast met en place un écosystème industriel entièrement intégré.Acier Vert : La Fondation d'une Industrie DurableUne étape cruciale dans cette
More news about: VinFast